Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

FDA, Compounder Reach Temporary Agreement, Firm Gets Wish For New Inspection

March 09, 2018
503B compounder Cantrell Drug Company and FDA have reached a temporary agreement to reinspect the facility after FDA moved to force the company to shut down and the compounder filed a subsequent restraining order against the government, according to a new document filed in the case on Friday (March 9). As Inside Health Policy reported, FDA and the Department of Justice filed a request for a preliminary injunction in the U.S. District Court for the Eastern District of Arkansas...